$XENE Cashflow Statement | Understand Stock

$XENE

$35.77 +$0.43 (1.22%) Close

$XENE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Interest receivable and accretion of discounts on marketable securities
Depreciation of property, plant and equipment
Amortization of discount on term loan
Non-cash operating lease expense
Deferred income tax recovery
Stock-based compensation
Realized loss on marketable securities
Unrealized foreign exchange (gain) loss
Unrealized fair value gain (loss) on marketable securities
Unrealized fair value gain on trading securities
Loss on repayment of term loan (note 11)
Changes in operating assets and liabilities:
Other receivables
Prepaid expenses and other assets
Accounts payable and accrued liabilities
Deferred revenue
Operating lease liability
Other liabilities

Net cash used in operating activities
Investing activities:
Purchases of property, plant and equipment
Purchase of marketable securities
Proceeds from marketable securities
Net cash provided by (used in) investing activities
Financing activities:
Repayment of term loan and repayment fees (note 11)
Proceeds from public offerings, net
Proceeds from offerings, net
Proceeds from exercise of stock options
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental cash flow disclosure:
Interest paid
Interest received
Cash paid for operating lease
Cash received for lease incentives

Supplemental disclosure of non-cash transactions:
Fair Value of Stock Options and Warrants Exercised on a Cashless Basis
Fair Value of Warrant and Pre-funded Warrants Exercised
Fair value of stock options exercised on a cashless basis
Fair value of pre-funded warrants exercised
Purchases of property, plant and equipment included in accounts payable and accrued expenses
Purchases of property, plant and equipment included in accounts payable and accrued liabilities
Right-of-use asset obtained in exchange for new operating lease liability
Increase in operating lease liability and accounts receivable related to lease incentives claimed in the period (note 8)
Increase in operating lease right-of-use asset and operating lease liability related to lease amendments (note 8)

Comments